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Abbreviations: CRR, counterregulatory responses; DMEM, Dulbecco’s modified Eagle 
medium; FBS, fetal bovine serum; FCCP, carbonyl cyanide-p-
trifluoromethoxyphenylhydrazone; HBS, Hepes buffered saline; ICV, 
intracerebroventricular; KATP, ATP-sensitive potassium channel; KIR6, inward rectifier 
potassium channel family 6; NN414 (tifenazoxide), 6-chloro-N-(1-methylcyclopropyl)-
1,1-dioxo-4H-thieno[3,2-e][1,2,4]thiadiazin-3amine; OCR, oxygen consumption rate; 
SUR1/2, sulphonylurea receptor 1/2; T1D, Type 1 Diabetes; TTA, Tris base, TES (N-
tris(hydroxylmethyl)methyl-1-L-aminoethine sulphonic acid, glacial acetic acid; VMH, 
ventromedial hypothalamus; 2DG, 2-deoxy-D-[3H]glucose; ∆Vm, membrane potential 
change. 
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Abstract  
Individuals with Type 1 diabetes (T1D) are often exposed to recurrent episodes of 
hypoglycaemia. This reduces hormonal and behavioural responses that normally 
counteract low glucose in order to maintain glucose homeostasis, with altered 
responsiveness of glucose sensing hypothalamic neurons implicated.  Although the 
molecular mechanisms are unknown, pharmacological studies implicate hypothalamic 
ATP-sensitive potassium channel (KATP) activity, with KATP openers (KCOs) amplifying, 
through cell hyperpolarisation, the response to hypoglycaemia.  Although initial 
findings, using acute hypothalamic KCO delivery, in rats were promising, chronic 
exposure to the KCO NN414 worsened the responses to subsequent hypoglycaemic 
challenge.  To investigate this further we used GT1-7 cells to explore how NN414 
affected glucose-sensing behaviour, the metabolic response of cells to hypoglycaemia 
and KATP activity.  GT1-7 cells exposed to 3 or 24 hr NN414 exhibited an attenuated 
hyperpolarization to subsequent hypoglycaemic challenge or NN414, which correlated 
with diminished KATP activity. The reduced sensitivity to hypoglycaemia was apparent 
24 hrs after NN414 removal, even though intrinsic KATP activity recovered.  The NN414-
modified glucose responsiveness was not associated with adaptations in glucose uptake, 
metabolism or oxidation. KATP inactivation by NN414 was prevented by the concurrent 
presence of tolbutamide, which maintains KATP closure. Single channel recordings 
indicate that NN414 alters KATP intrinsic gating inducing a stable closed or inactivated 
state.  These data indicate that exposure of hypothalamic glucose sensing cells to 
chronic NN414 drives a sustained conformational change to KATP, probably by binding 
to SUR1, that results in loss of channel sensitivity to intrinsic metabolic factors such as 
MgADP and small molecule agonists. 
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1. Introduction 
Individuals with Type 1 Diabetes (T1D) often experience repeated episodes of 
hypoglycaemia as a consequence of exogenous insulin therapy.  This recurring exposure 
to hypoglycaemia results in a reduction in the magnitude and altered threshold of 
symptomatic, hormonal and behavioural counterregulatory responses (CRR) to 
subsequent hypoglycaemia: a syndrome called impaired hypoglycaemia awareness 
(Adamson et al., 1984; Davis and Shamoon, 1991; Heller and Cryer, 1991; Inouye et al., 
2002; Jacobson et al., 2006; Sanders et al., 2006). This response to recurrent 
hypoglycaemia can also be elicited in rodent models, leading to the identification of 
altered glucose sensitivity of hypothalamic neurons as an important contributory 
mechanism (Alquier et al., 2007; Dunn-Meynell et al., 2002; Fioramonti et al., 2013; 
Kang et al., 2008; McCrimmon et al., 2005, 2006; Sanders et al., 2004; Song and Routh, 
2006).  Indeed it is now well established that the brain, in particular certain regions of 
the hypothalamus, regulates the physiological responses to hypoglycaemia in an effort 
to maintain whole body glucose homeostasis (Borg et al., 1994, 1995, 1997). 
Unfortunately, there are no effective treatments for defective CRR in type 1 diabetes 
other than the strict avoidance of hypoglycaemia that has only been achieved in 
intensive clinical trials involving small numbers of participants.  Therefore, there is an 
urgent requirement to identify alternative therapies and/or adjunct molecules that act 
centrally to prevent, or restore, defective CRR, but also to define their biological and 
pharmacological mechanisms.   
Central glucose sensing occurs in specialised neurons, many of which express the 
canonical proteins associated with pancreatic beta cell glucose sensing: glucokinase and 
ATP-sensitive potassium (KATP) channels (Ashford et al., 1990a, 1990b; Beall et al., 
2012; Claret et al., 2007; Kang et al., 2004, 2006; Tarasov et al., 2004).  Furthermore, the 
increased opening of hypothalamic KATP channels in glucose sensing neurons (resulting 
in neuronal hyperpolarization and inhibition of firing), in response to a fall in 
circulating glucose levels, is required to initiate an appropriate CRR to hypoglycaemia 
(Miki et al., 2001).  In vivo rodent studies have shown that direct microinjection of the 
KATP channel openers (KCOs), diazoxide or NN414 into the ventromedial hypothalamus 
(VMH), immediately prior to hypoglycaemia amplifies adrenaline and glucagon 
secretion during hyperinsulinaemic-hypoglycaemic clamp studies (McCrimmon et al., 
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2005). Additionally, VMH microinjection of diazoxide is also able to amplify the CRR 
following recurrent hypoglycaemia, in a rodent model of defective CRR (McCrimmon et 
al., 2005).  Conversely, intracerebroventricular (ICV) infusion or VMH microinjection of 
selective KATP inhibitors (which depolarize and increase neuronal firing), such as the 
sulphonylureas, glibenclamide or tolbutamide, attenuates the CRR during both systemic 
hypoglycaemia and cerebral glucopenia, resulting in blunted glucagon and adrenaline 
secretion (Evans et al., 2004).  
Consequently, it has been reasoned that agents, which act selectively to increase the 
opening of hypothalamic KATP channels, could be useful amplifiers of glucose counter-
regulatory responses.  KATP channels are composed of one of the two members of the 
inward-rectifier K+ channel family, KIR6 and one of the three forms of the sulphonylurea 
receptor (SUR) subunit family.  KATP channels that sub-serve glucose sensing in 
hypothalamic neurons express the SUR1 subunit (Ashford et al., 1990a; Dunn-Meynell 
et al., 1998; Kang et al., 2004; Lee et al., 1999; McCrimmon et al., 2005).  While diazoxide 
is capable of activating both SUR2 and SUR1 subtypes of KATP channels, NN414 is a SUR1 
selective agonist and has been shown to be a more potent activator than diazoxide of 
Kir6.2-SUR1 containing KATP channels (Dabrowski et al., 2003).  Initial studies on 
rodents demonstrated encouraging results, with acute systemic delivery of NN414 
resulting in an amplified CRR to hypoglycaemia, which was prevented by local delivery 
of glibenclamide to the VMH (Fan et al., 2003; McCrimmon et al., 2005).  Unexpectedly, 
chronic ICV infusion of NN414 to rats during antecedent hypoglycaemia induced a 
larger depression of the CRR to subsequent hypoglycaemic challenge (Beall et al., 2013).  
Furthermore, using GT1-7 neurons, an in vitro model of hypothalamic glucose sensing 
neurons that expresses Kir6.2-SUR1 containing KATP channels (Beall et al., 2012), it was 
demonstrated that chronic exposure to NN414 or diazoxide profoundly impaired the 
up-regulation of KATP channel activity in response to the removal of intracellular ATP 
(Beall et al., 2013).  Such an inactivation of hypothalamic KATP channels in vivo by 
chronic NN414 might explain the reduced CRR response to hypoglycaemia observed in 
rats. Consequently, we hypothesised that chronic hypothalamic KATP opening by KCOs 
may alter cellular metabolism and nucleotide levels and/or affect KATP gating directly 
resulting in maintained closure channel and diminished hypoglycaemic sensing.  
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  To investigate this phenomenon further we used GT1-7 neurons to determine the 
consequence of shorter-term exposure to KATP channel activators on glucose sensing 
and to examine whether one or more of these mechanisms underlie agonist-driven KATP 
channel inactivation.  
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2.  Materials and methods 
2.1. Cell culture 
Mouse hypothalamic GT1-7 cells (Pamela Mellon, San Diego, California, USA) (Mellon et 
al., 1990) were maintained in Dulbecco’s modified Eagle medium (DMEM; Gibco, 
Invitrogen, Paisley, UK) containing 2.5 mM glucose with 10% fetal bovine serum (FBS; 
PAA Laboratories, Yeovil, UK), as previously described (Beall et al., 2012). For 
continuous exposure to NN414 (5 µM; Novo Nordisk, Copenhagen, Denmark), diazoxide 
(250 µM; Sigma-Aldrich) or tolbutamide (200 µM; Sigma-Aldrich), cells were grown on 
poly-l-lysine-coated glass coverslips at ∼10–20% confluence. Vehicle-treated cells 
received 2 µl 0.1 M NaOH (NN414) or 0.1% DMSO (diazoxide, tolbutamide), with pH 
maintained at 7.4. In all experiments where GT1-7 cells underwent NN414 or vehicle 
challenge prior to electrophysiological or metabolic assessment, cells were superfused 
or washed thoroughly with normal saline (2.5 mM glucose) before measurements 
initiated. 
2.2.  Electrophysiology 
All electrophysiology experiments were conducted using an Axopatch 200B amplifier 
(Axon Instruments, Foster City, CA, USA) and analysed using PCLAMP7 software (Axon 
Instruments). GT1-7 cells were superfused at room temperature (22–25°C) with normal 
saline (in mM): 135 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, 0.5 or 2.5 glucose (pH 7.4). 
Membrane potentials were recorded using perforated-patch or whole-cell current-
clamp configurations, and membrane currents recorded using the whole-cell voltage 
clamp mode. In whole-cell experiments, cells were maintained in current-clamp mode 
to monitor resting membrane potential prior to a voltage clamp protocol to obtain 
current–voltage relations; whereby the cell was clamped at a holding potential of -70 
mV and voltage steps ranging from -90 mV to + 30 mV were elicited for a duration of 
400 ms at intervals of 20s (net range -160 to -40 mV).  Recording electrodes were 
pulled from thin borosilicate glass (open tip resistance of 3-5 MΩ) and filled with an 
intracellular solution containing (mM): 140 KCl, 5 MgCl2, 3.8 CaCl2, 10 EGTA, 10 HEPES, 
pH 7.2 (free [Ca2+] of 100 nM). Whole cell macroscopic currents were examined 
immediately (~1-2 minutes) after the cell membrane was ruptured (control) and after 
the cell had been dialysed (~12-15 minutes) with 0 ATP (by which time KATP channels 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 8 
were maximally open, termed run-up). Current- and voltage-clamp data were collected 
and analysed as described previously (Beall et al., 2010).  For perforated-patch 
recordings, the electrode solution contained (in mM): 140 KCl, 5 MgCl2, 3.8 CaCl2, 10 
HEPES, 10 EGTA (pH 7.2) and 25–40 μg/ml amphotericin B (Sigma-Aldrich). Following 
attainment of the perforated patch recording configuration, a minimum of 10 min of 
stable recording was collected in normal saline (2.5 mM glucose) before switching to a 
solution containing 0.5 mM glucose with or without tolbutamide (200 µM) (Sigma-
Aldrich) and/or NN414 (5 µM) or diazoxide (250 µM). 
For single channel recordings, patches of cell membrane were isolated and maintained 
in the inside-out configuration. Recording electrodes were pulled from thin walled 
borosilicate glass (open tip resistance of 10-12 MΩ) and filled with an intracellular 
solution containing (mM): 140 KCl, 1 MgCl2, 1 CaCl2, 10 HEPES, pH 7.2. The intracellular 
aspect of the membrane was exposed to a bathing solution containing (mM): 140 KCl, 1 
MgCl2, 2.7 CaCl2, 10 EGTA, 10 HEPES, pH 7.2 (free [Ca2+] of 100 nM). When 100 µM ATP 
was added to the bath, the [Mg2+] was raised to 1.1 mM to compensate for the Mg2+ 
chelation by ATP and maintain a free [Mg2+] of 65 nM. KATP channel activity was 
recorded for no longer than 15 minutes in order to avoid excessive channel run down, 
as previously reported (Larsson et al., 1993). 5 µM NN414, 200 µM MgADP or 100 
µg/ml Trypsin was acutely applied to patches in the presence of 100 µM ATP. The 
average channel activity in a patch was defined as N.Po, where N = the number of 
functional channels in the patch and Po = the open state probability, which was 
determined by measuring the total time spent at each unitary current level and 
expressed as a proportion of the total time of the segment of recording (90-120 
seconds) that was analysed. N.Po was calculated using the PCLAMP7 software which 
incorporates a 50% threshold parameter in order to detect single channel events which 
are > 50% of a predetermined unitary current amplitude. 
 
2.3. Glucose uptake 
GT1-7 cells were exposed to NN414 (5 µM) or vehicle for 24 hours prior to uptake 
analysis. Cells were washed in Hepes Buffered saline (HBS (in mM): 140 NaCl, 20 Hepes, 
5 KCl, 2.5 MgSO4, 1 CaCl2, 2.5 Glucose, pH 7.4) and serum-starved (1 hour) prior to 
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incubation (12 min) with 10 µM 2-deoxy-D-[3H]glucose (2DG; 24.4 kBq/ml; 
PerkinElmer, Cambridge UK) and 0, 0.1, 0.5 or 2.5 mM glucose at 20˚C. Non-specific 
uptake was determined using 10 µM cytochalasin B (Sigma-Aldrich). Following wash 
and cell lysis, cell-associated radioactivity was measured (Beckman LS60000IC 
scintillation counter; Beckman, High Wycombe, UK) and protein content quantified by 
Bradford reagent. Each uptake measurement was made up of 10 replicates. 
2.4. Glucose Oxidation 
 GT1-7 cells were pre-exposed to NN414 (5 µM) or vehicle for 24 hours and following 
wash with HEPES buffered saline (HBS) were incubated for 4 h with 74 kBq/ml D-[U-
14C]glucose (PerkinElmer) and 0.1, 0.5 or 2.5 mM glucose in HBS at 37˚C. Subsequently, 
the media were transferred to 15 ml tubes and the 14CO2 released using 200 µl 60% 
perchloric acid and trapped by Whatman (GF/B) filter paper discs pre-soaked in 1 M 
KOH. Radioactivity was quantified by liquid-scintillation counting. 
2.5. Hexokinase assay 
  GT1-7 cells were treated with NN414 (5 µM) or vehicle for 24 hours in 2.5 mM glucose, 
then washed with ice-cold HBS followed by ice-cold Tris base, TES (N-
tris(hydroxylmethyl)methyl-1-L-aminoethine sulphonic acid, glacial acetic acid (TTA) 
buffer before undergoing three freeze/thaw cycles, spun at 12000rpm at 4˚C for 10 
minutes followed by lysis. The hexokinase assay reaction mixture contained (in mM): 39 
TTA buffer (pH 7.6), 7.8 MgCl2, 1.1 β-NADP, 0.74 ATP, 2.5 U glucose-4-phosphate 
dehydrogenase, 0-100 glucose plus 5-10 µg of lysate, with the ATP added last to initiate 
the reaction.  Absorbance of β-NADPH was measured at 355nm at 30˚C.   
2.6. Cellular respiration 
 GT1-7 cells were seeded (30,000 cells/well) in XF 24-well culture microplates 
(Seahorse Bioscience, Copenhagen, Denmark) with NN414 (5 µM) or vehicle for 24 
hours in 2.5 mM glucose.  Cells were then washed in serum-free media (2.5 mM glucose) 
for 1 hour prior to measurements being taken.  Baseline recordings were taken to 
ensure a steady respiratory rate prior to injection of mitochondrial inhibitors for 
analysis of mitochondrial function. 
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2.7. Nucleotide assay 
 GT1-7 cell intracellular ATP/ADP ratios were determined by bioluminescence assay 
(ab65313, Abcam, Cambridge, UK). Cells were seeded (1000 cells/well) with NN414 (5 
µM) or vehicle for 24 hours in 2.5 mM glucose. Following cell lysis, luminescence 
intensity was determined by luminescence microplate reader (CentroPro LB 962 
Luminometer, Berthold Technologies, Bad Wildbad, Germany).  
2.8. Statistical analysis 
One-way ANOVA, with a post-hoc Bonferroni test, was used to determine statistical 
differences between 3 or more groups, such as in the electrophysiological recordings. 
All other data sets were analysed using an unpaired Student’s t-test (Graphpad, Prism 5 
software). Data are presented as mean ± SEM. Statistical significance was accepted at 
the 95% confidence value with a P value of less than 0.05. Significance was allocated to 
the following P values: * < 0.05; ** < 0.01 and *** < 0.001. 
 
3. Results 
3.1. Chronic exposure of GT1-7 cells to NN414 blunts hypoglycaemia detection 
As shown previously (Beall et al., 2012), perforated patch recordings from GT1-7 cells in 
2.5 mM glucose demonstrated spontaneous firing activity with a mean resting 
membrane potential of –50.7 ± 2.7 mV (n = 4), and following challenge with 0.5 mM 
glucose these neurons responded by hyperpolarization to –65.5 ± 1.9 mV with cessation 
of firing, effects reversible on return to 2.5 mM glucose-containing solution (–52.2 ± 2.6 
mV; Fig 1A).  In the continued presence of 2.5 mM glucose, application of the SUR1-
selective KATP activator, NN414 (5 µM) also rapidly hyperpolarized these neurons, to –
74.0 ± 2.0 mV, and inhibited firing (Fig 1A), an action reversible on washout of drug (not 
shown). When GT1-7 cells were exposed to 5 µM NN414 for 24 hours, after the removal 
of drug (recordings initiated within 30 minutes) we observed no difference in the mean 
resting membrane potential (–47.2 ± 2.2 mV; n = 6) or excitability of GT1-7 cells in 2.5 
mM glucose compared to control or vehicle treated cells (Fig 1B). However, these 
antecedent NN414-exposed cells no longer responded by hyperpolarization (Fig 1B) to 
challenge with 0.5 mM glucose (NN414 ∆Vm = –1.7 ± 0.8 mV; Vehicle, ∆Vm = –14.8 ± 2.8 
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mV; p < 0.001, n = 4-6; Fig 1C) and exhibited an attenuated response to further 
challenge with NN414, with the membrane potential hyperpolarizing from –45.0 ± 2.6 
mV to –59.2 ± 2.8 mV (NN414, ΔVm = -13.8 ± 1.8 mV; vehicle, ΔVm = -24.2 ± 2.6 mV; p < 
0.005, n = 6-9).  This outcome is not surprising as chronic (24 hrs or longer) treatment 
of GT1-7 cells with NN414 has been demonstrated to push KATP channels into a stable 
inactivated state (Beall et al., 2013). 
Next we examined whether a shorter-term exposure of GT1-7 cells to NN414 replicated 
this action on KATP conductance and resulted in attenuated glucose sensing. 
Consequently, we tested the effects of antecedent 3-hour NN414 or vehicle incubation 
on GT1-7 cell response to lowered glucose.  In agreement with longer-term exposure, 
following washout of NN414, GT1-7 cell membrane potential and firing rates were 
comparable between groups in 2.5 mM glucose-containing solution (Fig 1D,E). 
However, on challenge with 0.5 mM glucose, NN414-treated cells once again displayed a 
blunted hyperpolarization response to a low glucose challenge (NN414, ∆Vm = –0.8 ± 
0.5 mV; vehicle; ∆Vm = –12.4 ± 1.8 mV; p < 0.001, n = 5; Fig 1F) along with an 
attenuated response to acutely applied NN414 (NN414, ΔVm = -13.8 ± 2.9 mV; vehicle, 
ΔVm = -27.0 ± 3.8 mV; p < 0.01, n = 5). Consistent with a reduced KATP-responsiveness to 
either metabolic challenge or direct agonist application, whole-cell voltage clamp 
experiments on GT1-7 cells exposed to antecedent 3-hour NN414 revealed a 
significantly reduced maximal KATP current compared to vehicle-treated cells (Fig 1G).  
In addition, short-term exposure of cells to diazoxide (n = 5) produced a similar 
inhibition of maximal KATP conductance (Fig 1H).  
3.2. Chronic exposure to NN414 blunts hypoglycaemia detection in GT1-7 cells even 
following a 24hr wash out period 
We have previously shown that the chronic NN414 mediated suppression of KATP 
conductance in GT1-7 cells was completely reversible after 24 hours following washout 
of the drug (Beall et al., 2013).  This recovery of KATP conductance was also observed 24 
hours after washout from a 3-hour exposure to NN414 and was indistinguishable from 
vehicle-treated cells (Fig 2A-C). In addition, GT1-7 cells with antecedent vehicle 
exposure and 24-hour washout exhibited the typical response to lowered glucose and 
acute NN414 challenge (Fig 2D, E). However, there remained a significant reduction in 
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responsiveness to hypoglycaemia challenge in the antecedent NN414 exposed cells 
(Vehicle, ∆Vm = –14.3 ± 1.4 mV; NN414, ∆Vm = –3.8 ± 1.7 mV, n = 4-6; Fig 2F), and a 
diminished response to acute NN414 challenge (NN414, ΔVm = -16.9 ± 1.5 mV; vehicle, 
ΔVm = -23.4 ± 1.6 mV; p < 0.005, n = 9-10; Fig 2D, E).  Consequently, although the KATP 
channel availability (as defined in whole-cell conditions following washout of 
intracellular ATP) is recoverable 24 hours after washout of NN414, the channel appears 
to be much less available for opening by metabolic stimulus and so GT1-7 cells continue 
to display impaired glucose sensing.   
 
3.3. Chronic NN414 exposure does not alter the GT1-7 metabolic response to 
hypoglycaemia 
To dissect the mechanism behind the loss of glucose sensing following chronic NN414 
exposure, we first investigated whether the metabolic responsiveness of GT1-7 cells to 
hypoglycaemia was altered.  We chose 24-hour continuous NN414 as this duration of 
agonist exposure ensured the most robust attenuation of glucose sensing.  The 
hypothesis tested was that chronic NN414 exposure caused increased glucose uptake 
and/or more efficient metabolism, generating increased levels of ATP and so 
maintaining KATP closure during subsequent hypoglycaemic challenges.   However, we 
could not detect any alteration in glucose uptake (Fig 3A) or glucose oxidation and 
incorporation (Fig 3B,C) between chronic NN414-treated cells compared to vehicle 
controls, under physiological euglycaemic (2.5 mM) or hypoglycaemic (0.1 and 0.5 mM) 
conditions. Additionally, we did not observe any significant difference in hexokinase 
activity between NN414- and vehicle-treated cells (Fig 3D).  To examine whether 
NN414 exposure resulted in altered mitochondrial oxidative metabolism and cellular 
ATP production we examined the real-time oxygen consumption rate (OCR) of NN414- 
and vehicle-treated GT1-7 cells. The basal OCR was unaltered by NN414 in GT1-7 cells 
(Fig 3E).  In a further examination (Fig 3F-K) of mitochondrial efficiency we utilised a 
modified Mitochondrial Stress Test (Seahorse Bioscience). Thus ATP synthase was 
inhibited by the addition of oligomycin to measure the proportion of mitochondrial 
respiration dedicated to ATP production, followed by assessment of mitochondrial leak 
(addition of rotenone and antimycin A) and non-mitochondrial OCR, with no difference 
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detected in any of these parameters (Fig 3F-I). Furthermore the cellular reserve (“spare 
respiratory”) capacity of GT1-7 cells, as determined by the addition of the proton 
ionophore, carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), to induce 
maximal respiration, was also unaffected by previous exposure to NN414 (Fig 3J,K). 
Finally we measured the ATP/ADP ratio and, in agreement with the results above, 
NN414 exposure produced no change in this ratio (Fig 3L).  In summary, we detected no 
adaptations in glucose metabolism or mitochondrial function, which would help explain 
the attenuated glucose sensing following chronic NN414.  These results, in conjunction 
with the finding that direct activators of KATP exhibit reduced efficacy following NN414 
washout (even after recovery of KATP conductance in whole-cell recordings), suggested 
that alterations to the KATP channel itself may be responsible. 
 
3.4. NN414 binding to and opening of the KATP channel complex is required for NN414 
induced KATP inactivation 
Next we investigated the possibility that the induction of prolonged cell 
hyperpolarization resulted in a stable “inactivated” conformation of the KATP channel. To 
test this we increased the extracellular concentration of K+ to 13.5 mM in order to 
chemically-clamp the cell at resting membrane potential but still allow KATP channel 
opening by addition of NN414 without the attendant hyperpolarization, as shown in 
perforated-patch recordings from GT1-7 cells following acute exposure to NN414 (Fig 
4A).  Under chemical-clamp, we tested the effect of a 24-hour exposure of GT1-7 cells to 
NN414 or vehicle on the subsequent KATP conductance measured by whole-cell voltage 
clamp. The maximal conductance values determined from these cells following washout 
of ATP showed that chronic exposure to NN414 significantly attenuated the whole-cell 
KATP current and maximum conductance (Fig 4B-D) in a manner identical to that 
observed for cells undergoing hyperpolarization.  A similar outcome was also obtained 
with a shortened (3-hour) exposure to NN414 in the presence of 13.5 mM K+ solution 
(Fig 4E).  Consequently, we went on to examine whether the KATP inactivating effect of 
chronic NN414 exposure was dependent on the ability of the KATP channel to open.  To 
effect maintained channel closure, GT1-7 cells were exposed to the KATP channel 
inhibitor, tolbutamide (200 µM) and subsequently challenged with acute NN414, thus 
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demonstrating prevention of the hyperpolarizing response to the KATP activator (Fig 
5A).  For chronic NN414 treatment, tolbutamide was present 1 hour prior to NN414 
addition and continuous for the 24-hour NN414 incubation period, with appropriate 
vehicle controls. Subsequent whole-cell current- and voltage-clamp recordings 
demonstrated that, in the presence of tolbutamide + NN414, the maximal cell 
conductance following removal of the drugs was unchanged compared to their vehicle 
controls (Fig 5B-D), suggesting that NN414 is required to bind to the channel complex 
and open KATP for inactivation to occur. 
3.5. Chronic NN414 exposure induces a refractory state for neuronal KATP channels 
Although the availability of KATP to activate maximally is severely attenuated following 
continuous NN414 exposure, mRNA for the channel subunits KIR6.2 (Kcnj11) and SUR1 
(Abcc8) or the protein levels of the fully assembled channel complex at the plasma 
membrane were unchanged under these conditions (Beall et al., 2013).  Therefore, we 
performed single channel recordings on isolated inside-out membrane patches in order 
to determine if adaptations were occurring in the intrinsic activity of the KATP channel 
following prolonged NN414 exposure that contribute to the changes observed in 
glucose-sensing and subsequent KATP agonist sensitivity.  Following patch excision into 
the inside-out configuration in symmetrical 140 mM K+ solutions and assurance of 
stable recording conditions, the membrane potential was clamped at –50mV. Patches 
isolated from GT1-7 cells exposed for 24 hours to vehicle-containing solution exhibited 
typical KATP single channel activity, which was reversibly inhibited by the application of 
100 µM MgATP to the cytoplasmic aspect of the membrane (Fig 6A).  Furthermore, 
application of 200 µM MgADP to the membrane elicited KATP channel activation (Dunne 
et al., 1986; Kakei et al., 1986), and 100 µM NN414, in the presence of 100 µM MgATP 
(Dabrowski et al., 2003), induced a large increase in channel opening (Fig 6B, C), as 
expected.  In contrast, inside-out patches excised from GT1-7 cells following 24-hour 
exposure to NN414 were characterised by the relative absence of channel openings, 
indicating a substantial reduction in the intrinsic activity of the channel (Fig 6B,C top 
trace), with complete insensitivity to activation by application of 200 µM MgADP or 100 
µM NN414 + 100 µM MgATP (Fig 6B,C).  Finally, to ensure antecedent NN414-exposed 
cell-derived patches contained channels capable of being activated, patches were 
subsequently exposed to trypsin (100µg/ml), which has previously been demonstrated 
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to re-activate “run-down” KATP channels (Lee et al., 1994a; Proks et al., 1993). Exposure 
of patches to trypsin (2 minutes) yielded a comparable level of KATP activation in both 
treatment groups (NN414: N.Po = 0.265 ± 0.161; Vehicle: N.Po = 0.318 ± 0.20; Fig. 6B,C). 
 
4. Discussion 
There is a clear need to develop novel approaches to prevent hypoglycaemia in 
individuals with long-term T1D, as current strategies are relatively ineffective and 
hypoglycaemia remains the major limitation to intensive insulin therapy.  Studies on 
rats by microinjection of the non-selective KATP channel opener, diazoxide into the VMH 
(McCrimmon et al., 2005)  or by systemic delivery of the SUR1-selective opener, NN414 
(Fan., et al 2008) demonstrated promising results with the amplification of the CRR to 
hypoglycaemia.  Subsequently, ingestion of diazoxide by T1D subjects under 
hyperinsulinemic hypoglycaemic clamp demonstrated an improved CRR, which was 
diminished in individuals with a KATP channel polymorphism that is associated with 
diabetes (George et al., 2015).   
Conversely, we have previously demonstrated that continuous central NN414 exposure, 
rather than defending against the development of defective CRR in response to 
repetitive hypoglycaemic challenge, attenuates the CRR to hypoglycaemia in vivo and 
reduces KATP channel conductance density in vitro (Beall et al., 2013). Here we show 
that continuous NN414 application for 24 hours also blunted low-glucose sensing in the 
GT1-7 cell line.  Such an effect in vivo could therefore account for the suppression of the 
CRR to hypoglycaemia following chronic NN414 exposure. Although termination of 
NN414 administration in vivo partially restored the CRR response to hypoglycaemia and 
removal of NN414 from GT1-7 cells recovered whole-cell KATP conductance (Beall et al., 
2013), we find that the responsiveness of GT1-7 cells to hypoglycaemic challenge 
remains impaired.  One plausible explanation we explored was that chronic exposure to 
the KATP openers resulted in a “metabolic adaptation” leading to maintained levels of 
intracellular ATP under hypoglycaemic conditions, as has been reported for diazoxide in 
islets (Elmi et al., 2000). Thus we examined whether chronic NN414 exposure induced 
adaptations in cellular glucose metabolism or mitochondrial function in GT1-7 cells.  We 
found no significant changes in glucose uptake, hexokinase activity or glucose oxidation 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 16
in normo- or hypoglycaemic conditions nor did we observe any alteration in the oxygen 
consumption rate, mitochondrial electron transfer function or cytosolic ATP:ADP ratio 
in GT1-7 cells following chronic NN414 treatment in comparison with vehicle controls.  
As such a change in neuronal bioenergetics following KATP activation is unlikely to 
explain the persisting defect in glucose sensing. 
Consequently, we next focused on the possibility that long-term exposure to these 
channel openers resulted in a functional change in the KATP channel itself, either via 
prolonged hyperpolarization (voltage-dependent) per se or by binding of the KATP 
openers to the channel protein complex.  Using increased extracellular K+ concentration 
to chemically-clamp the membrane potential to ~-50 mV and prevent hyperpolarization 
by NN414, we demonstrated that chronic exposure to this channel opener still resulted 
in severely attenuated KATP cellular conductance.  In contrast, the presence of a selective 
KATP inhibitor, the sulphonylurea tolbutamide, which maintained the channel in the 
closed conformation prior to and during exposure to NN414, prevented the NN414-
mediated reduction in whole-cell KATP conductance. This outcome indicates that either 
the presence of tolbutamide prevents NN414 from binding to the KATP channel or that 
prolonged opening by the agonist, allosterically prevented by tolbutamide binding, 
results in the channel entering a stable inactivated state.  Although the exact binding 
site for the KATP openers has not yet been fully established, the selective agonist activity 
of NN414 is dependent on intact Walker A motifs of the nucleotide binding domains of 
SUR1 (Dabrowski et al., 2003). Furthermore, [3H]-glibenclamide binding to SUR1 can be 
displaced by NN414 (Neilsen et al., 2006) and tolbutamide (Niki et al., 1989) which has 
been demonstrated to bind to the COOH terminal group of SUR1 transmembrane 
domains (Ashfield et al., 1999) and may also interact with diazoxide at these and 
additional sites on SUR1 (Babenko et al., 2000).  
Nevertheless, regardless of the exact physical interaction site, prevention of KATP 
opening protects the channel from entering a long-lived closed or inactivated state. In 
an attempt to examine this further, we assessed single channel activity in excised 
patches following chronic NN414 or vehicle exposure of GT1-7 cells.  This revealed a 
severe loss of channel activity in patches excised from NN414-treated cells compared to 
vehicle controls, indicative of inhibition of the intrinsic gating activity of the channel in 
the absence of regulatory nucleotides. Furthermore, KATP opening could not be elicited 
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by the natural agonist MgADP applied to the intracellular aspect of the patch, in 
comparison to vehicle-treated channels, which responded with increased activity as 
expected (Dabrowski et al., 2003; Gribble et al., 1997a) or indeed by NN414 in the 
presence of MgATP (Dabrowski et al., 2003). The lack of responsiveness to MgADP is 
also consistent with the proposition that chronic NN414 treatment affects the gating 
capability of the channel through actions on SUR1 (Gribble et al., 1997b).  In an attempt 
to demonstrate that functional channels were still present in excised patches from 
NN414-treated GT1-7 cells, the protease trypsin was applied to the intracellular aspect 
of the membrane.  Previous studies have shown that trypsin re-activates KATP channels, 
which have been allowed to undergo the slow inactivation process termed “run-down” 
observed in inside-out patches from pancreatic β-cells (Lee et al., 1994a, 1994b). 
Indeed, we show that trypsin treatment re-activates channels in patches from chronic 
NN414-treated cells to the same extent as patches from vehicle-treated cells. This 
outcome is consistent with our finding that chronic NN414 does not affect KATP channel 
subunit trafficking to the plasma membrane (Beall et al., 2013).  Interestingly, trypsin 
treatment of the intracellular aspect of isolated patches severely reduces the sensitivity 
of KATP to inhibition by sulphonylureas, along with complete loss of [3H]-glibenclamide 
binding (Lee et al., 1994a).  A simple explanation for this outcome is that trypsin cleaves 
SUR1 (or at least the portion of SUR1 containing the binding site for sulphonylureas) 
from the KATP complex, thus also potentially removing any NN414 still bound to this site. 
Alternatively, trypsin treatment cleaves that part of the channel complex responsible for 
the sustained conformational change underlying the inactivated state, as has been 
described for other types of K+ channels (Hoshi et al., 1990; Kirsch and Brown, 1989; 
Solaro and Lingle, 1989). An interesting question that arises from these findings is 
whether KCOs induce this effect exclusively on hypothalamic neurons or it is a 
generalised action on KATP channels and may be observable in other tissues such as 
pancreatic beta cells? Additionally, to enable detailed examination of the biophysical 
nature of the KCO effect similar experiments should be performed on recombinant 
Kir6.2/SUR1 (or other subunit combinations) channels.  Such studies are currently 
underway. 
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In conclusion, although short-term application of KATP channel openers, such as the 
SUR1-selective opener NN414, appear to have excellent therapeutic potential for 
normalising defective CRR, the results from in vivo rodent work and our in vitro cellular 
data strongly suggests there may be a potential drawback with the use of such an agent 
given chronically as a preventative therapy.  Perhaps the development of structurally 
modified SUR1-selective KATP openers with lower efficacy or openers that act at a 
different site on the channel complex will circumvent this problem. Alternatively, lower 
dose NN414 or diazoxide and/or intermittent dosage regimes could be tested using this 
neuronal model and rodents in an attempt to obviate this difficulty prior to further trials 
in humans. 
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Figure Legends: 
Figure 1 Chronic NN414 treatment attenuates the hyperpolarization and conductance 
increase induced by low glucose and acute NN414 in GT1-7 cells.  
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(A, B) Representative perforated-patch current clamp recordings from GT1-7 cells 
exposed to vehicle (A) or 5 µM NN414 (B) for 24-hours. Acute application of 0.5 mM 
glucose to vehicle-treated cells results in membrane hyperpolarization and cessation of 
action potential activity, which is reversible on return to 2.5 mM glucose. In contrast, 
cells previously exposed to NN414 exhibit no response to 0.5 mM glucose. Subsequent 
acute challenge with 5 µM NN414 causes hyperpolarization in both cases, although this 
response is attenuated in the antecedent NN414-treated cells.  Bar graphs showing 
mean values for membrane potentials in 2.5 mM (white bars), 0.5 mM (black bars) 
glucose and 2.5 mM glucose + NN414 (grey bars) for cells exposed to vehicle (A; n = 4) 
of NN414 (B; n = 6). (C) Bar graph showing the mean change in membrane potential of 
cells exposed chronically to vehicle or NN414 (24-hours) on challenge with 0.5 mM 
glucose. (D, E) Representative perforated-patch current clamp recordings from GT1-7 
cells exposed to vehicle (D) or NN414 (E) for 3-hours. As observed for the 24-hour 
exposure, antecedent treatment with NN414 for 3-hours also blunted responses to 
acute 0.5 mM glucose and NN414 challenge. (F) Bar graph showing the mean change in 
membrane potential of cells exposed chronically to vehicle or NN414 (3-hours) on 
challenge with 0.5 mM glucose. (G) Conductance density for vehicle-treated (white bar) 
vs 3-hours NN414-treated (black bar) cells (n = 5). (H) Conductance density for vehicle-
treated (white bar) vs 3-hours 250 µM diazoxide-treated (black bar) cells (n = 5).  
Values are mean ± SEM.  * p<0.05, ** p<0.01, ***p<0.001.  
 
Figure 2 The NN414-associated suppression of KATP current is readily reversible but the 
response to low glucose and acute NN414 remains blunted, following drug washout. 
(A,B) Representative current-clamp recordings of membrane potential and voltage-
clamp recordings of currents from GT1-7 cells after 3-hour treatment in control 
(vehicle-treated; A) or NN414 (5 µM; B) and following washout.  Voltage-clamp currents 
are shown immediately after rupture, following run-up (ATP washed from cell) and 
after addition of 200 µM tolbutamide.  (C) Conductance density for vehicle-treated 
(white bar) and NN414-treated (black bar) cells (n = 6).  (D, E) Representative 
perforated-patch current clamp recordings from GT1-7 cells exposed to vehicle (D) or 5 
µM NN414 (E) for 3-hours followed by washout.  The hyperpolarizing responses to low 
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(0.5 mM) glucose and acute NN414 are blunted in the antecedent NN414-treated vs 
vehicle-treated cells. (F) Bar graph showing the mean change in membrane potential on 
challenge with 0.5 mM glucose of cells with antecedent exposure to vehicle or NN414 
(3-hours) followed by washout. (n = 6).   Values are mean ± SEM.  ** p<0.01. 
 
Figure 3 Chronic NN414 exposure does not alter glucose uptake and oxidation, 
mitochondrial function or nucleotide ratios in GT1-7 cells. 
(A-C) 2-deoxyglucose (2DG) uptake (A; n = 4), [14C]-glucose oxidation (B; n = 3) and 
total [14C]-glucose incorporation (C; n = 3) in 24 hr vehicle- and NN414-treated GT1-7 
cells, measured in 0.1, 0.5 and 2.5 mM glucose. (D) Activity of hexokinase as a function 
of glucose concentration in GT1-7 cells following 24-hour exposure to vehicle () or 
NN414 (). The curved lines (vehicle, solid; NN414, broken) represent lines of best fit 
to the data points (n = 4 determinations per point). (E) Oxygen consumption rate (OCR) 
of 24-hour vehicle- and NN414-treated GT1-7 cells. (F) Mitochondrial stress temporal 
profile for 24-hour vehicle- () and NN414-treated () GT1-7 cells showing the effects 
of the percentage change in normalized OCR of the sequential addition of 1 µM 
oligomycin and 2 µM rotenone and antimycin A (n = 7).  (G-I) 24-hour NN414 exposure 
had no effect on ATP-linked OCR (G), or on the OCR required to maintain the 
mitochondrial leak (H) or the non-mitochondrial OCR (I) compared to vehicle-treated 
cells (n = 7). (J) Temporal profile showing the normalised baseline OCR for vehicle- () 
and NN414-treated () cells and the maximum OCR (reserve capacity) attained 
following addition of 0.2 µM carboyl cyanide-trifluoromethoxyphenylhydrazone (FCCP). 
(K) 24 hr NN414 exposure had no effect on the percentage OCR increase following FCCP 
addition compared to vehicle-treated cells (n = 4). (L) the ATP-ADP ratio of GT1-7 cells 
was unchanged following 24 hr NN414 exposure, compared to vehicle controls (n = 9).  
Values are mean ± SEM.  
 
Figure 4 Chemical-clamp of cell membrane potential does not prevent chronic NN414 
from reducing KATP conductance. 
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(A) Representative perforated-patch current clamp recording of a GT1-7 cell 
demonstrating that acute NN414 application does not hyperpolarize the membrane 
potential in the presence of high extracellular (13.5 mM) KCl.  (B, C) Representative 
whole-cell current-clamp recordings of membrane potential and voltage-clamp 
recordings of currents from 24-hour KCl + vehicle- (B) and 24-hour KCl +NN414-treated 
GT1-7 cells (C). (D) Pooled conductance density at run-up from 24-hour KCl + vehicle- 
vs 24-hour KCl + NN414-treated cells (n = 11-12).  (E) Conductance density at run-up 
for 3-hour KCl + vehicle-treated vs 3-hour KCl + NN414-treated (black bar) cells (n = 
11).  Values are mean ± SEM. ** p<0.01, ***p<0.001. 
 
Figure 5 Tolbutamide prevents chronic NN414-associated attenuation of KATP channel 
conductance.  
(A) Representative perforated-patch current clamp recording of a GT1-7 cell 
demonstrating that 5 µM NN414 does not hyperpolarize the cell membrane when 
applied in the presence of 200 µM tolbutamide.  Note that addition of tolbutamide 
causes a small depolarization as reported previously (Beall et al., 2012).  (B, C) 
Representative whole-cell current-clamp recordings of membrane potential and 
voltage-clamp recordings of currents from 24-hour vehicle- (B) and 24-hour 
tolbutamide +NN414-treated GT1-7 cells (C).  (D) Pooled conductance density at run-up 
from 24-hour vehicle (white bars; n = 7) vs. 24-hour tolbutamide + NN414-treated cells 
(black bars; n = 5). Values are mean ± SEM. 
 
Figure 6 Chronic NN414 treatment drives KATP channels into an inactive state 
unresponsive to channel agonists. 
(A) Representative single channel recording from an isolated inside-out membrane 
patch from control GT1-7 cells, recorded in symmetrical 140 mM KCl at a membrane 
potential of -50 mV. Channel openings (inward current) are represented as downward 
deflections. The addition of 100 µM MgATP almost completely inhibits channel activity.  
(B) Representative inside-out single channel recordings from 24-hour vehicle-treated 
and 24-hour NN414-treated GT1-7 cells. This demonstrates that the intrinsic KATP 
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channel activity is higher in vehicle- vs. NN414-treated cells (top trace) and that the 
activation induced by addition of 200 µM MgADP (second trace) or 100 µM MgATP + 
100 µM NN414 (third trace) to the cytoplasmic aspect of the membrane observed in 24-
hour vehicle-treated cells is absent in the 24-hour NN414-treated cells.  In contrast, 100 
µg/ml trypsin application to the cytosolic domain of the inside-out patches elicited 
comparable responses between vehicle- and NN414-treated cells (bottom trace).  (C) 
Bar graph of mean KATP channel activity (N.Po) from inside-out patches obtained from 
24-hour vehicle- (white bars) and  24-hour NN414- (black bars) treated cells (n= 4-11).  
## denotes an N.Po value < 0.001. Values are mean ± SEM. * p<0.05, ** p<0.01, 
***p<0.001. 
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Highlights 
• Chronic exposure to NN414 blunts hypoglycaemic responses in GT1-7 
neurons. 
• NN414 does not cause adaptations in glucose metabolism. 
• The availability of KATP to open is greatly diminished by NN414 
• Preventing NN414 binding or conformation change to KATP rescues channel 
activity. 
